BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16818625)

  • 1. 4-nitroquinoline-1-oxide induces the formation of cellular topoisomerase I-DNA cleavage complexes.
    Miao ZH; Rao VA; Agama K; Antony S; Kohn KW; Pommier Y
    Cancer Res; 2006 Jul; 66(13):6540-5. PubMed ID: 16818625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of BLM, dissociation from topoisomerase IIIalpha, and colocalization with gamma-H2AX after topoisomerase I-induced replication damage.
    Rao VA; Fan AM; Meng L; Doe CF; North PS; Hickson ID; Pommier Y
    Mol Cell Biol; 2005 Oct; 25(20):8925-37. PubMed ID: 16199871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous gamma-H2AX-ATM-Chk2 checkpoint activation in Bloom's syndrome helicase deficient cells is related to DNA replication arrested forks.
    Rao VA; Conti C; Guirouilh-Barbat J; Nakamura A; Miao ZH; Davies SL; Saccá B; Hickson ID; Bensimon A; Pommier Y
    Mol Cancer Res; 2007 Jul; 5(7):713-24. PubMed ID: 17634426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PARP-1-dependent RND1 transcription induced by topoisomerase I cleavage complexes confers cellular resistance to camptothecin.
    Mouly L; Mamouni K; Gence R; Cristini A; Cherier J; Castinel A; Legrand M; Favre G; Sordet O; Monferran S
    Cell Death Dis; 2018 Sep; 9(9):931. PubMed ID: 30209297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Werner and Bloom helicases are involved in DNA repair in a complementary fashion.
    Imamura O; Fujita K; Itoh C; Takeda S; Furuichi Y; Matsumoto T
    Oncogene; 2002 Jan; 21(6):954-63. PubMed ID: 11840341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the Bloom syndrome protein with topoisomerase IIIalpha in somatic and meiotic cells.
    Johnson FB; Lombard DB; Neff NF; Mastrangelo MA; Dewolf W; Ellis NA; Marciniak RA; Yin Y; Jaenisch R; Guarente L
    Cancer Res; 2000 Mar; 60(5):1162-7. PubMed ID: 10728666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and chromosomal hypersensitivity to DNA crosslinking agents and topoisomerase inhibitors in the radiosensitive Chinese hamster irs mutants: phenotypic similarities to ataxia telangiectasia and Fanconi's anaemia cells.
    Jones NJ; Ellard S; Waters R; Parry EM
    Carcinogenesis; 1993 Dec; 14(12):2487-94. PubMed ID: 8269616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic and DNA binding properties of purified WRN protein: high affinity binding to single-stranded DNA but not to DNA damage induced by 4NQO.
    Orren DK; Brosh RM; Nehlin JO; Machwe A; Gray MD; Bohr VA
    Nucleic Acids Res; 1999 Sep; 27(17):3557-66. PubMed ID: 10446247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavage of the Bloom's syndrome gene product during apoptosis by caspase-3 results in an impaired interaction with topoisomerase IIIalpha.
    Freire R; d'Adda Di Fagagna F; Wu L; Pedrazzi G; Stagljar I; Hickson ID; Jackson SP
    Nucleic Acids Res; 2001 Aug; 29(15):3172-80. PubMed ID: 11470874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Batracylin (NSC 320846), a dual inhibitor of DNA topoisomerases I and II induces histone gamma-H2AX as a biomarker of DNA damage.
    Rao VA; Agama K; Holbeck S; Pommier Y
    Cancer Res; 2007 Oct; 67(20):9971-9. PubMed ID: 17942930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bloom's syndrome helicase stimulates the activity of human topoisomerase IIIalpha.
    Wu L; Hickson ID
    Nucleic Acids Res; 2002 Nov; 30(22):4823-9. PubMed ID: 12433984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase.
    Lefevre D; Riou JF; Ahomadegbe JC; Zhou DY; Benard J; Riou G
    Biochem Pharmacol; 1991 Jun; 41(12):1967-79. PubMed ID: 1645555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bloom helicase and DNA topoisomerase IIIalpha are involved in the dissolution of sister chromatids.
    Seki M; Nakagawa T; Seki T; Kato G; Tada S; Takahashi Y; Yoshimura A; Kobayashi T; Aoki A; Otsuki M; Habermann FA; Tanabe H; Ishii Y; Enomoto T
    Mol Cell Biol; 2006 Aug; 26(16):6299-307. PubMed ID: 16880537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methyleugenol and oxidative metabolites induce DNA damage and interact with human topoisomerases.
    Groh IA; Rudakovski O; Gründken M; Schroeter A; Marko D; Esselen M
    Arch Toxicol; 2016 Nov; 90(11):2809-2823. PubMed ID: 26542539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase II and tubulin inhibitors both induce the formation of apoptotic topoisomerase I cleavage complexes.
    Sordet O; Goldman A; Pommier Y
    Mol Cancer Ther; 2006 Dec; 5(12):3139-44. PubMed ID: 17172417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA damage induced by DNA topoisomerase I- and topoisomerase II-inhibitors detected by histone H2AX phosphorylation in relation to the cell cycle phase and apoptosis.
    Huang X; Traganos F; Darzynkiewicz Z
    Cell Cycle; 2003; 2(6):614-9. PubMed ID: 14504478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BLM is required for faithful chromosome segregation and its localization defines a class of ultrafine anaphase bridges.
    Chan KL; North PS; Hickson ID
    EMBO J; 2007 Jul; 26(14):3397-409. PubMed ID: 17599064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for BLM and Topoisomerase IIIalpha interaction in genomic stability.
    Hu P; Beresten SF; van Brabant AJ; Ye TZ; Pandolfi PP; Johnson FB; Guarente L; Ellis NA
    Hum Mol Genet; 2001 Jun; 10(12):1287-98. PubMed ID: 11406610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Various inhibitors of DNA topoisomerases diminish repair-specific DNA incision in UV-irradiated human fibroblasts.
    Thielmann HW; Popanda O; Gersbach H; Gilberg F
    Carcinogenesis; 1993 Nov; 14(11):2341-51. PubMed ID: 8242865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome breakage is regulated by the interaction of the BLM helicase and topoisomerase IIalpha.
    Russell B; Bhattacharyya S; Keirsey J; Sandy A; Grierson P; Perchiniak E; Kavecansky J; Acharya S; Groden J
    Cancer Res; 2011 Jan; 71(2):561-71. PubMed ID: 21224348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.